The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant - Quiz - MDSpire

The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant

  • By

  • Saurabh Zanwar

  • Eapen K. Jacob

  • Carl Greiner

  • Kevin Pavelko

  • Michael Strausbauch

  • Emilie Anderson

  • Arini Arsana

  • Megan Weivoda

  • Mithun Vinod Shah

  • Taxiarchis Kourelis

  • September 26, 2023

  • 0 min

Share

Original Source(s)

The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant

  • by Saurabh Zanwar, Eapen K. Jacob, Carl Greiner, Kevin Pavelko, Michael Strausbauch, Emilie Anderson, Arini Arsana, Megan Weivoda, Mithun Vinod Shah, Taxiarchis Kourelis

  • September 26, 2023

Related Content

Bone marrow hemodilution assessment in multiple myeloma MRD by next generation flow cytometry - a mini review

Impact of clinical surveillance on myeloma-related complications in patients with precursor plasma cell disorders

A single next generation sequencing assay for detection of driver mutations, rearrangements and copy number abnormalities in plasma cell dyscrasias